• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    May 12, 2021

    Media Contact:

    Deidre McCabe, Director, Office of Communications, 410-767-3536

    Charlie Gischlar, Deputy Director, Media Relations, 443-463-7234 

    Maryland Department of Health Statement on FDA and CDC Support of the Pfizer-BioNTech COVID-19 Vaccine for Adolescents Aged 12 to 15

    On Monday, May 10, the Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine to expand its use in adolescents 12 to 15 years of age. FDA said in a statement:

    “The FDA has determined that Pfizer-BioNTech COVID-19 vaccine has met the statutory criteria to amend the EUA, and that the known and potential benefits of this vaccine in individuals 12 years of age and older outweigh the known and potential risks, supporting the vaccine’s use in this population.”

    Earlier today, the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) issued recommendations for the use of the Pfizer-BioNTech vaccine. In officially accepting ACIP’s recommendations, CDC Director Dr. Rochelle Walensky said:

    “For vaccination to do its job, we must do our critical part. That means vaccinating as many people as possible who are eligible. This official CDC action opens vaccination to approximately 17 million adolescents in the United States and strengthens our nation’s efforts to protect even more people from the effects of COVID-19. Getting adolescents vaccinated means their faster return to social activities and can provide parents and caregivers peace of mind knowing their family is protected.”

    The Maryland Department of Health (MDH) strongly supports use of the Pfizer-BioNTech vaccine in adolescents 12 to 15 years of age, and encourages providers to make appointments available to this population immediately.

    “The Pfizer-BioNTech COVID-19 vaccine has met FDA’s rigorous scientific standards for safety and effectiveness in adolescents aged 12 to 15,” said MDH Deputy Secretary for Public Health Services Dr. Jinlene Chan. “In clinical trials with thousands of participants aged 12 to 15, the Pfizer-BioNTech vaccine demonstrated 100% efficacy against infection and robust antibody responses, and it was well tolerated.”

    COVID-19 vaccines for adolescents aged 12 to 15 are available currently at the following locations:

    • Eleven of Maryland's mass vaccination sites. No appointment is required, although Marylanders can book an appointment to guarantee a time slot.
    • 300 pharmacies across the state. Schedule an appointment at the location most convenient for your adolescent.

    Visit COVIDvax.Maryland.gov to find a comprehensive directory and book appointments at sites that are able to accommodate patients aged 12 to 15. 

    In the coming weeks, COVID-19 vaccines will be available to adolescents aged 12 to 15 in a growing number of locations, to include pediatricians’ offices and other community locations.

    “One of our primary goals is to ensure that vaccines are accessible to adolescents through several distribution points,” added Chan. “By working with pediatricians, schools, primary care physicians, and other community providers, we will make it easy for this newly eligible age group to get the vaccines needed to stay safe and help the state recover fully. We encourage families that have questions to contact their child’s healthcare provider.”​

    Pediatricians and other healthcare providers should carefully review FDA’s fact sheets for Healthcare Providers Administering the Vaccine (Vaccination Providers) and for Recipients and Caregivers.


    The Maryland Department of Health is dedicated to protecting and improving the health and safety of all Marylanders through disease prevention, access to care, quality management and community engagement.